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Abstract 
The human skeleton has a remarkable regeneration capacity. Nevertheless, 5–10 % of the bone fractures fails to heal 
and develops into a non-union which is a challenging orthopedic complication requiring complex and expensive 
treatment. This review paper will discuss four different computational models, each capturing a particular clinical case 
of non-union: non-union induced by reaming of the marrow canal and periosteal stripping, non-union due to a large 
interfragmentary gap, non-union due to a genetic disorder [i.e. NF1 related congenital pseudoarthrosis of the tibia 
(CPT)] and non-union due to mechanical overload. Together, the four computational models are able to capture the 
etiology of a wide range of fracture non-union types and design novel treatment strategies thereof. Further research 
is required to corroborate the computational models in both animal and human settings and translate them from 
bench to bed side.
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Background
In case of injury, the majority of bone fractures can heal 
without the production of scar tissue. Unfortunately, 
fracture healing complications, such as delayed and non-
unions, are associated with 5–10 % of the over 6 million 
fractures occurring annually in the USA [1, 2]. Fracture 
non-unions are challenging orthopedic complications 
requiring complex and expensive treatment including 
multiple surgical procedures and prolonged hospital stay 
[3–5]. As such, the resulting socio-economic burden is 
significant and rising according to the 2010 Global Bur-
den of Disease study where musculoskeletal disorders 
accounted for 6–8 % of total disability-adjusted life years 
(DALYs) [6].
Although the field of orthopedics has experienced 
great advancements in the last decades, more knowledge 
of the complex physiological process of bone healing is 
a prerequisite for the prevention and effective treatment 
of complex fractures. (Patient-specific) Computational 
models have the potential to cope with this complexity. 
Moreover, computational models can help to integrate all 
the relevant, patient-specific information into a personal-
ized diagnosis and optimal treatment.
This article will focus on the use of in silico models to 
improve our fundamental understanding of impaired 
bone regeneration and to design novel treatment strat-
egies. It will first briefly summarize the biology of bone 
regeneration, including possible complications and treat-
ment options. Subsequently, the added value of com-
putational models will be illustrated with four different 
clinical cases of non-unions: non-union induced by 
reaming of the marrow canal and periosteal stripping, 
non-union due to a large interfragmentary gap, non-
union due to a genetic disorder (i.e. NF1 related congeni-
tal pseudoarthrosis of the tibia (CPT)) and non-union 
due to mechanical overload. Finally, some prospects and 
conclusions will be formulated.
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Biology of bone fracture healing
Normal and impaired bone regeneration
Primary bone healing, during which the fracture will 
heal similar to the normal bone remodeling process, will 
only occur under optimal mechanical conditions, i.e. a 
mechanically stabilized fracture with either extremely 
low interfragmentary movement or bony fragments that 
are under compression. The more common type of heal-
ing, i.e. secondary bone healing, is associated with a low 
degree of stability and the formation of a periosteal cal-
lus. Briefly, the characteristic course of long bone heal-
ing can be subdivided in four main stages (Fig. 1): (1) the 
“inflammation phase” where the trauma site becomes 
hypoxic and is invaded by inflammatory cells, fibroblasts 
and mesenchymal stem cells, (2) the “reparative phase” 
which starts with the production of a cartilaginous and 
fibrous tissue template (“soft callus phase”), later invaded 
by new blood vessels and replaced by a bony callus 
through endochondral ossification (“hard callus phase”), 
(3) the final “remodeling phase” during which the woven 
bone is replaced by lamellar bone and the vasculature is 
reorganized.
Although bone has a unique restorative capacity, the 
conditions for spontaneous bone healing are not always 
present leading to a delayed union or a non-union. The 
former is generally defined as the eventual bony union 
after an atypical long period of healing, in comparison to 
the normal healing period [7, 8]. The latter is character-
ized by an absence of healing during at least 6–12 months 
(in humans). The different types of fracture non-unions, 
i.e. hypertrophic, atrophic or oligotrophic, and synovial 
pseudarthrosis are classified based on their radiographic 
and histological appearance [7, 9].
Hypertrophic non-unions are mainly defined by an 
abnormal vascularity and abundant callus formation. 
In this type of non-union, the excessive motion at the 
fracture site prevents the bony bridging although the 
essential biological factors are present [7]. Atrophic non-
unions, however, are the result of inadequate biological 
conditions. They show little callus formation around the 
gap, which is mostly filled with fibrous tissue and little 
or no mineral deposition as evidenced by the blunted 
bony ends on radiographs [7]. Oligotrophic non-unions 
combine the radiographic characteristics of atrophic 
non-unions, i.e. little to no callus formation, with the bio-
logical characteristics of hypertrophic non-unions, i.e. 
normal biological activity [10]. In a synovial pseudarthro-
sis the fracture gap of the non-union is a fluid-filled cav-
ity with a synovial-like membrane.
Current treatment strategies
Of the classical therapeutic methods currently avail-
able to treat non-unions, amputation is the treatment of 
last resort [11]. Even when other treatment options are 
available, the choice is complex since at a more phenom-
enological level the outcome of bone healing depends 
on many mechanical and biological risk factors, such as 
excess motion, the interfragmentary gap size [12], the 
type of fracture [12–14], the particular bone [11], loca-
tion of the trauma within the bone [11], loss of blood 
supply [15]. Additional injuries such as severe periosteal 
and soft-tissue trauma [13, 14] as well as other preexist-
ing patients risk factors including old age [16], cachexia 
and malnutrition [17], immune compromise [18], genetic 
disorders (e.g. neurofibromatosis type 1 [19]), osteopo-
rosis [20], anticoagulants [21], smoking [22] and anti-
inflammatory agents [23], may also compromise the 
optimal treatment.
Strategies for hypertrophic non-unions traditionally 
aim to restore the optimal mechanical environment for 
fracture healing [7, 24]. Enhanced stabilization and pro-
gressive compression such as in the Ilizarov method can 
allow to convert the abnormal fibrous, cartilaginous and 
adipose tissues between the mobile bony ends into bone 
without the need to remove them. In case of plate osteo-
synthesis a debridement is usually performed as the frac-
ture is exposed anyway, whereas in intramedullary nailing 
the reaming of the canal contributes to the refreshment 
of the fracture zone. The key to success either with plates, 
intramedullary nails or external fixators is the reduction 
of any excessive motion allowing a sound biomechanical 
condition for bone healing [7, 24–28].
Successful healing of the more challenging (atrophic) 
non-unions will, however, not only require the removal 
Fig. 1 Schematic representation of the four different phases of frac-
ture healing. I the inflammatory phase, II the soft tissue callus phase, 
III the hard callus phase and IV the remodeling phase
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of scar tissue and adequate stabilization of the fracture 
but also biological support (e.g. bone grafting, adminis-
tration of growth factors) [7]. Large quantities of bone 
are not only required for compromised bone healing pro-
cesses, they are also indispensable for skeletal reconstruc-
tions of large bone defects created by trauma, infection, 
tumor resection and skeletal abnormalities [29]. A widely 
used approach to stimulate or augment bone formation 
is distraction osteogenesis, a clinical procedure where 
bone regeneration is induced between two gradually dis-
tracted bony surfaces [30, 31]. This principle is applied 
in the bone transport technique, allowing huge defects 
to be replaced [32, 33]. However, due to the length of the 
treatment, as well as the technical demands and com-
plications associated with distraction osteogenesis [30, 
31], a number of bone grafting methods are more com-
monly performed in clinical practice when the defect size 
is not too extensive. Autologous bone grafting, i.e. the 
process by which bone is harvested from one anatomical 
site and transplanted to another site in the same patient, 
is still considered the “gold standard” since it effectively 
combines the required osteoinductive, osteogenic and 
osteoconductive properties [34]. It has, however, sev-
eral limitations which include donor site pain, increased 
blood loss, increased surgery times, increased risk for 
donor site infection and limited supply [35]. An even 
more complex autologous bone transplant is the vascu-
larized bone graft such as the fibula, which can be used 
to replace long-sized bone defects [36]. Allogeneic bone 
grafts, where bone is harvested from human cadavers, 
sterilized and transplanted to the patient, lack donor site 
morbidity but are expensive and have an increased risk of 
viral transmission [7]. Moreover, they have very limited 
biological activity as they are only osteoconductive with-
out any osteogenic capacity and only sporadically a small 
osteoinductive capacity. As such they are inappropriate 
to treat atrophic non-unions. The use of synthetic cal-
cium salt-based bone substitutes is sometimes suggested 
as an alternative to both autologous and allogeneic grafts 
since they are inexpensive and lack the risks of donor site 
morbidity and viral transmission [37]. They are, however, 
only osteoconductive which limits their potential biologi-
cal role in fracture healing [7, 38] and as such they cannot 
be recommended as a stand-alone treatment in ham-
pered bone healing. The use of a “Masquelet-membrane” 
is to be considered as an enhanced bone grafting method 
which consists of two steps. In the first stage a polymeth-
ylmetacrylate cement spacer is placed in the defect which 
induces the formation of a vascularized membrane. In 
the second stage a non-vascularized graft will be inserted 
in the newly formed vascularized envelope which serves 
as a source of oxygen, nutrients and a cocktail of impor-
tant growth factors [39, 40]. Besides bone grafting also 
bioactive molecules have been used to augment fracture 
healing. BMP-2 and BMP-7 have been shown to have sig-
nificant osteogenic and angiogenic properties, which has 
led to their use in a variety of clinical conditions includ-
ing non-unions, open fractures and joint fusions [29, 
41]. An alternative approach is the local application of 
platelet-rich plasma, which is rich in many of the growth 
factors implicated in bone regeneration [42]. Another 
promising strategy, which could potentially overcome 
the limitations of current bone regeneration therapies, is 
tissue engineering where an optimal bone healing micro-
environment is created by seeding cells (osteogenesis) 
and growth factors (osteoinduction) on biocompatible 
scaffolds (osteoconduction) that will be implanted in a 
mechanically stabilized defect [43].
In silico modeling of bone fracture non‑unions
Over the last decades computational models of fracture 
healing have progressed from static, linear elastic mod-
els to dynamic poroelastic analyses, accounting for callus 
growth and several biological factors including growth 
factors, cells and vascularization [44]. In this section we 
will use four different clinically relevant case-studies to 
illustrate the potential of computational models, initially 
developed for normal fracture healing, to investigate the 
etiology and treatment of fracture non-unions (Fig.  2). 
For further information on the bioregulatory and mech-
anoregulatory algorithms used in these computational 
models we refer the reader to some reviews [44–47].
Modeling framework
The four clinically-relevant case-studies presented 
here are all derived from the same general modeling 
Fig. 2 Schematic representation of the four different causes of non-
union. I non-union induced by reaming of the marrow canal and peri-
osteal stripping, II non-union due to a critical size defect, III non-union 
due to a genetic disorder, i.e. NF1 related congenital pseudarthrosis 
of the tibia and IV non-union due to mechanical overload
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framework. More specifically, the general mathemati-
cal model describes the key processes of bone regenera-
tion as a function of time and space, using a number of 
continuum-type of variables (such as growth factor con-
centration, cell densities and matrix densities). The bone 
regeneration processes are captured by a system of par-
tial differential equations (PDEs) of the taxis-diffusion–
reaction type of which the general structure is as follows:
where t represents time, x the space and cm(t, x) the den-
sity of a migrating cell type (i.e. mesenchymal stem cell, 
fibroblast and endothelial cells). c(t, x) represents the 
vector of the other cell densities, matrix densities and 
growth factor concentrations. Dcm(cm) and D are the dif-
fusion coefficients, fi(c) represents the taxis coefficients 
for chemotaxis and haptotaxis. f0(cm, c) and g(cm, c) are 
the reaction terms describing cell proliferation, differen-
tiation and apoptosis as well as matrix and growth factor 
production and decay. The equations are solved on a sim-
plified (fixed) geometrical domain of the fracture callus 
(Fig.  3). The current implementation of the framework 
assumes a constant callus size and axisymmetry so that 
only a quarter of the domain is simulated (Fig. 3). In order 
to ensure the existence, uniqueness and non-negativity of 
the solution, the system of Eqs. (1)–(2) is complemented 
by suitable initial and boundary conditions (Fig. 3), which 
are dependent on the specific case-study.
Although the four cases-studies are based on the same 
general framework, there are some important differ-
ences which are detailed below and summarized in Fig. 3. 
Firstly, only case-study IV includes the role of mechanical 
influences on the healing processes for which the finite 
element analyses were carried out in MSC.Marc Men-
tat (Version 2005r2, Palo Alto, USA). The bioregulatory 
model of all case studies is solved in a custom finite vol-
ume code using Matlab (The MathWorks, Inc.). Secondly, 
case studies I and IV use a continuous description of bone 
regeneration (tissue level), including a continuous vascu-
lar density, whereas case studies II and III use a multi-
scale description that combines a continuous tissue-level 
with a discrete cellular level (i.e. the vascular tree) and a 
detailed intracellular signaling network (i.e. Dll4-Notch 
signaling in the endothelial cells). Thirdly, case studies 
I and IV discriminate between a generic osteogenic (gb) 
and chondrogenic (gc) growth factor, whereas case stud-
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growth factor, whose influence of differentiation is either 
chondrogenic or osteogenic depending on the local oxy-
gen tension. A complete description of the set of equa-
tions, the boundary and initial conditions, the parameter 
values, implementation details as well as some underlying 
assumptions and simplifications can be found in previous 
publications of the respective cases: case I [48], case II 
[49], case III [50], case IV [51].
Periosteal and endosteal injury
As described above, atrophic non-unions are typically 
the result of inadequate biological conditions [7], e.g. a 
limited blood supply, a lack of growth factors and/or pro-
genitor cells caused by periosteal and endosteal injury. 
These different aspects of atrophic non-unions, as well 
as some treatment strategies were rigorously investi-
gated by Geris et al. in a combined experimental-mode-
ling approach [48]. The experimental set-up consisted of 
a clinically relevant model of atrophic non-union in the 
rat. In short, a 1  mm gap was introduced at the site of 
the tibial osteotomy, the periosteum was stripped and the 
intramedullary canal curetted for a distance of one tib-
ial diameter, both proximally and distally [52]. The frac-
tures were fixated with a circular frame external fixator 
using nylon rings and copper screws [52]. In this study, 
the focus was on the bioregulatory aspects of atrophic 
non-unions so the influence of mechanical stimuli was 
neglected in the computational model. To simulate the 
atrophic non-union case, the domain was extended at 
the distal end (away from the fracture site) to represent 
the stripping of the periosteum and reaming of the mar-
row canal in the experimental set-up (Fig.  3I). Interest-
ingly, only when both the periosteum was stripped and 
the marrow canal was reamed the occurrence of a non-
union was predicted. In other cases, the removal of a 
MSC source resulted in a delayed healing, which con-
firmed the key role of progenitor cells in the beginning 
of the healing cascade. After careful validation of the 
mathematical model, a possible treatment strategy was 
designed in silico and tested in  vivo in order to restore 
the adequate biological conditions lacking in atrophic 
non-unions. At postosteotomy week (POW) three, 1 ml 
of MSCs was administered in the center of the callus at a 
concentration of 106 cells/ml (Fig. 4Ai). POW 3 was cho-
sen to allow recovery of the blood supply in the gap since 
blood vessel formation is often delayed in (atrophic) non-
union cases. The model of Geris et al. predicted a gradual 
increase in bone formation after administration of MSCs 
up till POW 16 (Fig.  4Ai) [48]. This was corroborated 
by the experimental results that showed bony bridging 
in three of the four treatment animals and significantly 
more bone formation in the treatment group than in the 
control group (Fig. 4Aii). Interestingly, the exact location 
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of the injection appeared to be crucial, with excentral 
injection leading to unicortical bridging (Fig. 4Bi) or even 
the formation of a bony layer at the outside of the callus 
which would prevent the invasion of other cells from the 
surrounding tissues (Fig. 4C) [48].
Non‑union due to large interfragmentary gap
A large interfragmentary gap is a known biological risk 
factor for the development of a non-union [12]. In order 
to investigate the influence of the gap size on the healing 
outcome, Carlier et  al. first established an in silico and 
in  vivo murine non-union model [53]. They demon-
strated that the in silico murine bone defect becomes 
critical at 3 mm, which corresponds to other experimen-
tal observations: 2 mm [54], 3 mm [55], 3.5 mm [56] and 
4 mm [57]. They also showed that the biological poten-
tial of the fracture callus, i.e. the amount of stem cells 
and growth factors present in the fracture callus after the 
inflammatory phase, has an important impact on the final 
amount of bone formation. In critical size defects the 
Fig. 3 Comparison of the computational frameworks used to model the four different causes of non-union. I non-union induced by reaming of the 
marrow canal and periosteal stripping [48], II non-union due to a critical size defect [49], III non-union due to a genetic disorder, i.e. NF1 related con-
genital pseudarthrosis of the tibia [50] and IV non-union due to mechanical overload [51]. GFs growth factors, cm mesenchymal stem cell density, 
cf fibroblast cell density, cb osteoblast cell density, cc chondrocyte cell density, gbc generic osteochondrogenic growth factor, gb generic osteogenic 
growth factor, gc generic chondrogenic growth factor, gv generic angiogenic growth factor, cv endothelial cell (density), uz displacement in the 
z-direction, ur displacement in the r-direction, p hydrostatic pressure, Fz applied loading, 1 periosteal callus, 2 intercortical callus, 3 endosteal callus
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biological potential is, however, not sufficient to result 
in complete healing due to insufficient vascularization of 
the central callus area, leading to hypoxic conditions and 
cell death [53]. In a next step Carlier et al. applied differ-
ent combinations of boundary conditions to the in silico 
model to explore the role of the surrounding muscle 
envelope as a source for vascularization, progenitor cells 
and growth factors. They conclude that the host environ-
ment, and more specifically its role as a source for vascu-
larization is critical for successful bone healing. Intrigued 
by these results, Carlier et al. [49] designed in silico treat-
ment strategies for critical size defects surrounded by a 
permissive and a compromised host environment. In a 
permissive host environment, the fracture callus is par-
tially supplied by blood vessels from the overlying mus-
cle which improves the bone formation but nevertheless 
results in a non-union. A compromised environment is 
characterized in the in silico model by the absence of 
any influx from the host environment. Interestingly, the 
in silico model predicts that the injection of growth fac-
tors at day 0 results in a complete healing in a permissive 
host environment. The injection of cells or a combina-
tion product improve the bone healing outcome but do 
not rescue the healing process [53]. In a compromised 
environment, the injection of MSCs or a combination 
of MSCs and growth factors elicited an improved bone 
healing response (although without reaching full bridg-
ing) in silico if the environment is sufficiently vascular-
ized to sustain the cell viability, which according to the 
model results meant a delay of injection until a certain 
time point (i.e. 35 days for MSCs, 49 days for the com-
bination product) (Fig. 5) [53]. Growth factor injections 
Fig. 4 In silico and in vivo results of the effects of MSC transplantation on atrophic non-union formation. Ai In silico results for the treatment with 
the cell transplant injected in the center of the callus. Aii A comparison of experimentally measured (Exp) and numerically calculated (Sim) tissue 
constituents present within the interfragmentary gap of control (carrier solution injected) and treatment (MSC transplant) groups (o*p < 0.005, 
students t test). Simulation results are shown for a central injection of the carrier solution. Bi In silico results for the treatment with the cell trans-
plant injected excentrally in the callus. Bii A comparison of experimentally measured (Exp) and numerically calculated (Sim) tissue constituents 
present within the interfragmentary gap of control (carrier solution injected) and treatment (MSC transplant) groups (o*p < 0.005, students t-test). 
Simulation results are shown for an excentral injection of the carrier solution. C Simulation results for the treatment with the cell transplant injected 
outside the callus. PFW post fracture week. (adapted from Geris et al. [48], licensed under CC BY 4.0)
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at later time points in a compromised environment are, 
however, to no avail, since there are no cells left in the 
central callus area due to the hypoxic conditions (Fig. 5).
Non‑union due to a genetic disorder
Congenital pseudarthrosis of the tibia (CPT) is an orphan 
disease with an incidence of 1 per 53 000 births [58]. The 
clinical presentation varies between a primary pseudar-
throsis at birth to (extensive) anterolateral bowing of the 
tibia during early infancy and spontaneous fractures in 
the distal third of the tibia when the child begins walk-
ing [19, 59]. Although the exact etiology of CPT is highly 
debated, 40–80  % of the CPT-patients are carriers of 
a mutation in the Neurofibromatosis type 1 (NF1) gene, 
which can potentially result in an altered phenotype of 
the skeletal cells and impaired bone healing. To examine 
the effect of the NF1 mutation on bone fracture healing, 
Carlier et  al. altered the parameter values of the factors 
describing the aberrant cellular behaviour of NF1 haplo-
insufficient and NF1 bi-allelically inactivated cells in an 
established computational model of bone fracture heal-
ing [50]. The computational results showed that a com-
bination of aberrant processes in skeletal cells, attributed 
in literature to the presence of a NF1 mutation, may lead 
to the prediction of a non-union including large quantity 
of fibrous tissue and limited endochondral ossification 
[50]. The relative importance of the eight altered factors 
to the model outcome was further explored in a large 
sensitivity analysis. Interestingly, the results of the sensi-
tivity analysis clustered in two classes, one corresponding 
to impaired healing and one to normal healing (Fig.  6). 
A closer look at these findings indicated that the rate of 
cartilage formation (Fig.  6a), the rate of endochondral 
ossification (Fig. 6b) and the duration of fibroblast inva-
sion (Fig.  6c) were the most important determinants of 
this behavior. Consequently, the computational model 
suggests that future research efforts should be focused 
on the characterization of the endochondral ossifica-
tion pathway in NF1 haploinsufficient and NF1 bi-allel-
ically inactivated cells as well as that of the invasion of 
lesional cells in the fracture callus in order to unravel the 
exact etiology of CPT and improve current treatment 
strategies.
Clearly, this type of approach can give interesting 
insights into the varieties in phenotypes that can result 
from defects in a single gene. Even though at this moment 
it is not feasible to link patient-specific characteristics to 
a particular combination of model parameters, valuable 
information can be obtained at the population level. Cur-
rently we are testing treatments involving BMP admin-
istration in the entire simulated population in order to 
understand the cause of the highly variable outcome of 
this treatment reported in the literature [60–62]. As such, 
this case-study represents an important step towards 
real in silico clinical trials, where it is envisioned that 
computer models would be able to predict the efficacy 
of a “virtual” treatment on a group of “virtual” patients 
[63]. Such in silico clinical trials could help to refine 
and reduce the size and duration of real clinical trials 
through better a design. Moreover, they have the poten-
tial to complement and replace real clinical trials, which 
would be particularly promising for orphan diseases 
(such as NF1-associated CPT), where only small cohorts 
of patients are available for clinical investigation, and for 
pediatric diseases where clinical trials are nearly impos-
sible for ethical reasons.
Non‑union due to mechanical overload
As stated above, adverse mechanical loading is known 
to be a major risk factor of delayed unions and (hyper-
trophic) non-unions [7]. However, the exact mechanisms 
by which mechanical (over)loading influences the regen-
erative processes during fracture healing are unknown. 
Geris et  al. used a mechanobioregulatory model to 
investigate the influence of local mechanical stimuli on 
the angiogenic and osteogenic processes resulting in 
non-unions [51]. To simulate the effects of mechanical 
Fig. 5 Predicted amount of bone formation at post fracture day 
(PFD) 90 in a critical size defect surrounded by a compromised 
environment as a function of the PFD at which a particular treatment 
was initiated. The compromised environment was modeled as the 
absence of any influx from the host environment and the treatment 
consisted of a single injection of growth factors, cells or a combina-
tion thereof. Note that a delayed injection of only growth factors does 
not improve the bone formation outcome. The injection of MSCs is 
only beneficial when delayed until PFD 35 whereas the combination 
yields better results at PFD 56. Importantly, although the amount of 
bone is increased, none of the treatments results in complete healing 
of the bone defect (adapted from [49], licensed under CC BY 4.0)
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loading, interstitial fluid flow and hydrostatic pressure 
were chosen as mechanical stimuli, influencing either 
angiogenic parameters (i.e. endothelial cell prolifera-
tion, blood vessel synthesis, VEGF production by chon-
drocytes, blood vessel degradation) or a combination of 
parameters related to angiogenesis and intramembra-
nous (i.e. osteoblast proliferation, MSC differentiation 
to osteoblasts, bone synthesis) and endochondral ossifi-
cation (i.e. chondrocyte replacement) (Fig.  3). Solely in 
the case of a combined influence of mechanical loading 
(interstitial fluid flow) on angiogenesis and intramem-
branous and endochondral ossification, a non-union 
due to mechanical overloading was predicted (Fig.  7b). 
Further analysis of these simulation results showed that 
the required angiogenic factors are present in the frac-
ture callus but that the adverse mechanical environment 
prevents the new vasculature from forming. If the local 
mechanical stimuli influence only angiogenesis, full bony 
bridging is observed for both normal and overloading 
conditions. For intermediate loading, the initial healing 
response was slightly delayed but this was compensated 
by a faster endochondral reaction (results not shown). In 
the case of underloading, an incomplete union (bridg-
ing without endochondral ossification in the periosteal 
callus) developed (results not shown). The above find-
ings are corroborated by experimental and clinical stud-
ies emphasizing the importance of appropriate loading 
conditions for normal progression of bone regenera-
tion. Interestingly, Geris. et  al. [64] demonstrated that, 
depending on the dominating biology-mechanics inter-
actions that are implemented in the computational 
model, different treatment strategies are required for 
the restoration of normal healing. For example, when 
proliferation, osteogenic differentiation, bone matrix 
production and endochondral ossification are the most 
influenced by mechanical loading, both adequate stabi-
lization of the fracture environment and administration 
of sufficient osteogenic growth factors are necessary to 
result in complete healing (Fig.  7c–f ). However, when 
mechanical loading mainly influences proliferation, 
Fig. 6 Results of the sensitivity analysis of the NF1 model. The horizontal axis shows the value of the parameter and the vertical axis shows the 
value of the complication index (CI) on Day 21. The CI value assess the degree of severity of CPT and is an averaged value of the amount of fibrous 
tissue, fibroblasts and bony union. A parameter combination for which the value of CI is small, is one for which the degree of severity of CPT is small 
(the fracture healing proceeds fairly normally). The dots indicate the actual results obtained from the computational model (each dot represents the 
CI response obtained for a particular combination of parameter values of the NF1 model), and the solid line indicates the statistical prediction by a 
Gaussian process. Note that the actual results (the dots) split up in two classes: one for which the CI value is high, resulting in impaired bone healing 
and one for which the CI value is low. In case (d), the dots are present in both classes, regardless of the parameter values. In cases a, b, parameter 
values below 0.05 and 200 respectively, always lead to a high CI value (indicated by the arrow), whereas in case (c) parameter values below 10 result 
in low to intermediate CI values (indicated by the arrow) (adapted from [50], licensed under CC BY 4.0)
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osteogenic differentiation and bone matrix production, 
the administration of osteogenic growth factors leads to 
a bony union 3  weeks after treatment, with or without 
removing the overload conditions (results not shown) 
[64]. From these results we can conclude that under 
comparable mechanical and biological conditions, the 
bone healing outcome can substantially differ from one 
patient to the other.
Fig. 7 Fracture healing evolution under several loading conditions and treatment strategies. Evolution of the fibrous, cartilaginous and bone 
tissue fractions in the fracture callus under several loading conditions (the mechanical stimulus (i.e. interstitial fluid flow) influences angiogenesis, 
intramembranous and endochondral ossification): a healing under normal biological and mechanical conditions, b overloading (400 % of the 
normal load). c–f depict the results of various treatment strategies for overload-induced non-unions (the mechanical stimulus (i.e. interstitial fluid 
flow) influences proliferation, osteogenic differentiation, bone matrix production and endochondral ossification). Treatments of overload-induced 
non-unions started at 3 weeks post fracture (PFW3) as, by then, the first signs of endochondral ossification should have been visible in a normal 
healing process. The star symbol indicates the timing of the schematically depicted treatment. c stabilization of the callus area after 3 weeks of 
healing under unstable conditions (overloading) does not result in recapitulation of normal-healing processes, d administration of additional 
osteogenic growth factors (OGF, gb) at PFW3 without stabilization does not result in recapitulation of the normal healing process, e stabilization of 
the callus area in combination with the administration of sufficient osteogenic growth factors (0.1 mg/ml1) at PFW3 results in recapitulation of the 
normal healing process. f stabilization of the callus area in combination with the administration of osteogenic growth factors in a lower concentra-
tion (0.01 mg/ml) at PFW3 results in a slower recapitulation of the normal healing process when compared with (biv). (with kind permission from 
Springer Science + Business Media: Geris et al. [51], Fig. 6; adapted from [51, 64])
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Prospects
The above examples clearly illustrate that in silico tech-
niques are able to investigate the etiology of a wide range 
of fracture non-union types and design novel treatment 
strategies thereof. More specifically, the first case-study 
demonstrated that the computational model can capture 
the essential aspects of an in  vivo atrophic non-union 
and can help to explain and optimize experimental treat-
ments, i.e. the location of the injection of a cell trans-
plant. Similarly, the predictions of the second case-study 
showed that the effectiveness of a therapy, consisting 
of a single injection of osteochondrogenic growth fac-
tors, cells or a combination thereof in a large segmental 
bone defect, is strongly influenced by the (patient-spe-
cific) host environment and by the timing of injection. 
Moreover, case-study four evidenced that, depending 
on the dominating biology-mechanics interactions that 
are implemented in the computational model, different 
treatment strategies are required for the restoration of 
normal healing. As such, the results of these three case-
studies clearly underline the need for patient-dependent 
modeling. However, at this moment it is not (yet) feasi-
ble to link patient-specific characteristics to a particular 
combination of model parameters (an in depth dis-
cussion of the key challenges associated with patient-
specific modeling can be found in [65]). Nevertheless, 
case-study three nicely shows that the current approach 
can give interesting insights at the population level and 
represents an important first step towards in silico clini-
cal trials.
The current computational framework has some limi-
tations and the interpretation of the results should there-
fore be done carefully due to the following reasons. 
Firstly, the computational model only includes the repair 
phases of fracture healing, i.e. the soft and hard callus 
phase, and neglects the early inflammatory response and 
the bone remodeling phase. Other fracture healing mod-
els have accounted for the remodeling phase such as the 
work of Gómez-Benito et al. [66], Burke et al. [67], Byrne 
et al. [68] and Shefelbine et al. [69]. Moreover, in the lit-
erature also detailed models exist of the bone remodeling 
process itself, including the studies of Ryser et al. [70, 71] 
and Buenzli et  al. [72–74]. However, none of the state-
of-the-art fracture healing models, to the author’s best 
knowledge, captures the inflammatory phase.
Secondly, the presented computational framework 
requires a simplified and fixed geometrical domain of a 
fracture callus (Fig. 3). As such, the implementation can-
not account for tissue growth during callus formation, 
although this can be captured in the frameworks of Chen 
et al. [75], Simon et al. [76] and Gomez-Benito et al. [66]. 
Moreover, the computational framework only allows 
2D or 2D-axisymmetric calculations while others have 
simulated the regeneration processes in the inter-cortical 
region in 3D [68, 69, 77].
Thirdly, the computational model is based on experi-
mental data from mouse models since these small animal 
models are increasingly used in bone healing studies due 
to their less expensive housing, shorter breeding cycles, 
well-defined genetic background and available (genetic) 
methods to study particular molecular mechanisms of 
action [78]. However, rodents have a more primitive bone 
structure without a Haversian system and use resorp-
tion cavities for bone remodeling, which is different 
from large animals and adults [78]. Moreover, in order 
to correctly mimic fracture healing in adults, animals of 
an age with completed bone growth should be used [79]. 
Given that the computational model is corroborated with 
experimental data from mouse models, it is important to 
keep in mind the differences that exist between murine 
and human bone healing when extrapolating these find-
ings to a clinical setting. Note that others have used ovine 
models to explore the predictive power of computational 
models of bone healing. Moore et al. report for example 
that the histological measures (amongst others Giemsa-
Eosin staining and fluorochrome microscopy) match the 
predicted gradients in BMP, cells and tissue fractions over 
time in an ovine critical size defect model [80]. Similarly, 
Chen et al. corroborate their predictions on the induction 
of non-unions in large gap sized and different mechanical 
conditions with experimental results obtained from an 
osteotomized ovine metatarsus [75].
Despite the above mentioned advances, several steps 
need to be taken in order to bring in silico models from 
bench to bed side [65]. These steps include, amongst 
others, the establishment of patient-specific models as 
well as their corroboration in both small (e.g. mice) and 
large (e.g. sheep) animal models and a limited number 
of patient-specific study cases. Although this road to 
translation is challenging, we believe that it is important 
to focus future research efforts to overcome these chal-
lenges so that computational models of bone fracture 
healing are not only used as research tools in the experi-
mental research phase but also aid in the advancement 
of individualized care and reduction of the associated 
health care costs.
Conclusion
In case of injury, the majority of bone fractures can heal 
without the production of scar tissue. Unfortunately, 
5–10  % of the bone fractures fails to heal and develops 
into a non-union. This review illustrated the potential of 
computational models of fracture healing in contribut-
ing to a more profound understanding of the etiology and 
treatment of fracture non-unions. Four different cases 
of non-unions were discussed: non-union induced by 
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periosteal and endosteal injury, non-union due to a large 
interfragmentary gap, non-union due to a genetic disor-
der (i.e. NF1 related congenital pseudoarthrosis of the 
tibia (CPT)) and non-union due to mechanical overload. 
Clearly, a treatment will be most beneficial if it tackles 
the underlying mechanism of action causing the ham-
pered bone formation. The underlying mechanisms of 
action are, however, the result of complex non-linear bio-
logical and mechanical interactions occurring at various 
temporal and spatial scales. As such, a rigorous approach 
where in vivo and in silico methods work in tandem, are 
essential to deepen our fundamental understanding of 
(impaired) bone regeneration, to corroborate the exist-
ing computational models and to bring novel treatment 
strategies for challenging orthopedic cases from bench to 
bed side.
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